SEC Form 4 · accession 0001209191-17-066553
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Sarah B. Noonberg
Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 8:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.57 | Dec 15, 2017 | A | 24,000 | A | — | Dec 14, 2027 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of December 12, 2017.